If your practice draws up, mixes, or infuses anything — vitamin drips, NAD+, peptides, aesthetic injectables — you're working under the standards that govern sterile compounding. Here's how to tell which lane you're in.
You give a manufactured or 503B product exactly as labeled — no mixing, no repackaging. This isn't compounding, so those rules don't apply. The simplest place to be.
Simple mixing for one patient, given right away. Legal without a cleanroom — if you can check all seven boxes below.
Drawing from compounded vials, batching, or storing means you need an ISO Class 5 hood and a real program around it — often just a hood in a dedicated spot, a full cleanroom only to batch or store.
Miss even one, and you've stepped out of the immediate-use lane into territory that needs a cleanroom.
A product from a compounding pharmacy or a 503B outsourcing facility is not an FDA-approved drug — so no approved label lets you add it to an IV bag. Draw it up and mix it, and you're compounding; that vial should be accessed inside an ISO Class 5 hood, not on an open counter. A ready-to-administer 503B product you simply hang is fine.
Re-entering a single-dose vial for several patients, or saving the leftovers, isn't allowed. Single-dose means single patient.
That's normal — these rules are genuinely confusing. A readiness assessment walks your practice and tells you exactly where you stand and what, if anything, to fix — before an inspector does.
Request a readiness assessment